Evidence map›Paper›PMID 31861146›Full record

ArticleCancers2019

Magnetic Silica-Coated Iron Oxide Nanochains as Photothermal Agents, Disrupting the Extracellular Matrix, and Eradicating Cancer Cells.

Jelena Kolosnjaj-Tabi, Slavko Kralj, Elena Griseti, Sebastjan Nemec, Claire Wilhelm, Anouchka Plan Sangnier, Elisabeth Bellard, Isabelle Fourquaux, Muriel Golzio, Marie-Pierre Rols

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Cancer Nanomedicine.Cancers · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jelena Kolosnjaj-TabiInstitute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.ORCID 0000-0002-0144-9622
Slavko KraljDepartment for Materials Synthesis, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0771-3818
Elena GrisetiInstitute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.
Sebastjan NemecDepartment for Materials Synthesis, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia.
Claire WilhelmLaboratoire Matière et Systèmes Complexes (MSC), UMR 7057, Bâtiment Condorcet, Université Paris Diderot, 10 rue Alice Domon et Léonie Duquet, 75205 Paris, France.
Anouchka Plan SangnierFaculty of Pharmacy, University of Ljubljana, Askerceva cesta 7, 1000 Ljubljana, Slovenia.ORCID 0000-0002-4799-7149
Elisabeth BellardInstitute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.
Isabelle FourquauxCentre de Microscopie Electronique Appliquée à la Biologie (CMEAB), Faculté de Médecine Rangueil, 133 Route de Narbonne, 31400 Toulouse, France.
Muriel GolzioInstitute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.ORCID 0000-0002-7470-3708
Marie-Pierre RolsInstitute of Pharmacology and Structural Biology, 205 Route de Narbonne, 31400 Toulouse, France.
Institut de Pharmacologie et de Biologie Structurale · FRUniversity of Ljubljana · SIUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancerous cells and the tumor microenvironment are among key elements involved in cancer development, progression, and resistance to treatment. In order to tackle the cells and the extracellular matrix, we herein propose the use of a class of silica-coated iron oxide nanochains, which have superior magnetic responsiveness and can act as efficient photothermal agents. When internalized by different cancer cell lines and normal (non-cancerous) cells, the nanochains are not toxic, as assessed on 2D and 3D cell culture models. Yet, upon irradiation with near infrared light, the nanochains become efficient cytotoxic photothermal agents. Besides, not only do they generate hyperthermia, which effectively eradicates tumor cells in vitro, but they also locally melt the collagen matrix, as we evidence in real-time, using engineered cell sheets with self-secreted extracellular matrix. By simultaneously acting as physical (magnetic and photothermal) effectors and chemical delivery systems, the nanochain-based platforms offer original multimodal possibilities for prospective cancer treatment, affecting both the cells and the extracellular matrix.

Indexed as

cancercellular microenvironmentcollagenhyperthermiamagnetic silica-coated iron oxide nanochainsnanoparticlesphotothermal treatment

Identifiers

PMID31861146
PMCPMC6966508
OpenAlexW2995333962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.